interferon (Zeneca)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Nameinterferon (Zeneca)
Drug Alias Namealpha1-IF (Zeneca)antiviral (Zeneca)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionInterferon alpha ligand
TargetsInterferon alpha
Therapy Area/IndicationsVirus Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesZeneca Group Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesZeneca Group Plc
Active IndicationsN/A
Inactive IndicationsVirus Diseases

Other Information

ATC CodeN/A
Related LinksN/A